Topiramate for smoking cessation: a randomized, placebo-controlled pilot study.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Nicotine & Tobacco Research

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ntr/ntt141PMID 24057996PMCID PMC3920334
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pharmacotherapy of Obesity: Clinical Treatments and Considerations

  2013cited by this paper
• Comparative efficacy and tolerability of anti‐epileptic drugs for refractory focal epilepsy: systematic review and network meta‐analysis reveals the need for long term comparator trials

  2013cited by this paper
• Weight change associated with antiepileptic drugs

  2012cited by this paper
• New perspectives in glutamate and anxiety.

  2012cited by this paper
• Obsessive-Compulsive Disorder, Impulse Control Disorders and Drug Addiction

  2011cited by this paper
• Interventions for preventing weight gain after smoking cessation.

  2009cited by this paper
• Treating Tobacco Use and Dependence: 2008 Update

  2008influential reference
• Effectiveness of topiramate for tobacco dependence in patients with depression; a randomised, controlled trial

  2008cited by this paper
• Preliminary evidence for gender-specific effects of topiramate as a potential aid to smoking cessation.

  2008influential reference
• Nicotine replacement therapy for smoking cessation.

  2008cited by this paper
• Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings.

  2008cited by this paper
• A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report.

  2008cited by this paper
• A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.

  2007cited by this paper
• Effects of topiramate on cue-induced cigarette craving and the response to a smoked cigarette in briefly abstinent smokers

  2007cited by this paper
• Topiramate in treatment of depressive and anger symptoms in female depressive patients: a randomized, double-blind, placebo-controlled study.

  2005cited by this paper
• Add-on topiramate reduces weight in overweight patients with affective disorders: a clinical case series

  2005cited by this paper
• Biphasic actions of topiramate on monoamine exocytosis associated with both soluble N-ethylmaleimide-sensitive factor attachment protein receptors and Ca(2+)-induced Ca(2+)-releasing systems.

  2005cited by this paper
• Effects of topiramate in combination with intravenous nicotine in overnight abstinent smokers

  2005cited by this paper
• Effects of tiagabine in combination with intravenous nicotine in overnight abstinent smokers

  2005cited by this paper
• Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial.

  2005cited by this paper
• Correction: actual causes of death in the United States, 2000.

  2005cited by this paper
• Molecular Pharmacology of Topiramate: Managing Seizures and Preventing Migraine

  2005cited by this paper
• Topiramate-induced neuromodulation of cortico-mesolimbic dopamine function: a new vista for the treatment of comorbid alcohol and nicotine dependence?

  2004cited by this paper
• Actual causes of death in the United States, 2000.

  2004cited by this paper
• Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women.

  2001cited by this paper
• Tobacco treatment services should be covered under Medicaid

  1998cited by this paper
• Errors in using tobacco withdrawal scale

  1998cited by this paper
• Nicotine-mecamylamine treatment for smoking cessation: the role of pre-cessation therapy.

  1998cited by this paper
• Actual causes of death in the United States.

  1994cited by this paper
• Weight gain following smoking cessation.

  1993cited by this paper
• The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire.

  1991cited by this paper
• Reliability of a timeline method: assessing normal drinkers' reports of recent drinking and a comparative evaluation across several populations.

  1988cited by this paper
• Evaluation of Biochemical Validation Measures in Determination of Smoking Status

  1987cited by this paper
• Weight gain following smoking cessation.

  1986cited by this paper

• High‐ and low‐dose topiramate for the treatment of persons with alcohol use disorder who smoke cigarettes: A randomized control trial

  2025cites this paper
• Dynamic associations between cannabis use and sleep in adolescents and young adults during a cannabis intervention trial.

  2025cites this paper
• Emerging pharmacotherapy for the treatment of cannabis use disorder

  2024cites this paper
• Study title: A systematic review of RCTs to examine the risk of adverse cardiovascular events with nicotine use

  2023influential citation
• Treatment of Adolescent Cannabis Use Disorders.

  2023cites this paper
• Bupropion/zonisamide combination to assist smokers to switch from combustible cigarettes to electronic nicotine delivery systems (ENDS).

  2022cites this paper
• Behavioral economic analysis of topiramate pharmacotherapy for alcohol: a placebo-controlled investigation of effects on alcohol reinforcing value and delayed reward discounting

  2022cites this paper
• Treatment of Adolescent Cannabis Use Disorders.

  2022cites this paper
• Pharmacological interventions on smoking cessation: A systematic review and network meta-analysis

  2022cites this paper
• Consideration of sex and gender differences in addiction medication response

  2022cites this paper
• Topiramate decreases the salience of motivationally relevant visual cues among smokers with alcohol use disorder.

  2022cites this paper
• Behavioral economic analysis of topiramate pharmacotherapy for alcohol: a placebo-controlled investigation of effects on alcohol reinforcing value and delayed reward discounting

  2022cites this paper
• Cessation classification likelihood increases with higher expired-air carbon monoxide cutoffs: a meta-analysis.

  2021cites this paper
• Use of Topiramate in the Spectrum of Addictive and Eating Disorders: A Systematic Review Comparing Treatment Schemes, Efficacy, and Safety Features

  2021influential citation
• Acute Angle-Closure Crisis Secondary to Topiramate-Induced Ciliochoroidal Effusion With Underlying Plateau Iris Configuration

  2021cites this paper
• Interventions for preventing weight gain after smoking cessation.

  2021cites this paper
• Combined pharmacotherapy and evidence-based psychosocial Cannabis treatment for youth and selection of cannabis-using friends.

  2021cites this paper
• The effectiveness of technology-based interventions for smoking cessation: An umbrella review and quality assessment of systematic reviews.

  2021cites this paper
• Topiramate for smoking cessation: Systematic review and meta-analysis

  2020cites this paper
• Therapeutic Strategies in Alcohol and Tobacco Addiction

  2020cites this paper
• Kobe University Repository : Kernel タイトル Tit le Current pharmacologic t reatments for smoking cessat ion and new agents undergoing clinical t rials

  2020cites this paper
• Therapeutische Strategien bei Alkohol- und Tabakabhängigkeit

  2020cites this paper
• Epilepsy and aging.

  2019cites this paper
• Topiramate Pharmacotherapy for Alcohol Use Disorder and Other Addictions: A Narrative Review

  2019cites this paper
• Effects of different pharmacologic smoking cessation treatments on body weight changes and success rates in patients with nicotine dependence: A network meta‐analysis

  2019cites this paper
• Quantitative Determination of Topiramate in Human Serum and Umbilical Cord Blood

  2019cites this paper
• Randomized Clinical Trials Investigating Innovative Interventions for Smoking Cessation in the Last Decade.

  2019cites this paper
• Can the use of varenicline improve the efficacy of pharmacotherapy for nicotine addiction?

  2019cites this paper
• Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials

  2019cites this paper
• Predictors of Topiramate Tolerability in Heavy Cannabis–Using Adolescents and Young Adults: A Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

  2018cites this paper
• Current and Emerging Pharmacotherapies for Cessation of Tobacco Smoking

  2018cites this paper
• Topiramate versus naltrexone for alcohol use disorder: study protocol for a genotype-stratified, double-blind randomised controlled trial (TOP study)

  2018cites this paper
• Cannabis Use Disorder as a Developmental Disorder

  2018cites this paper
• Topiramate Confers Neuroprotection Against Methylphenidate-Induced Neurodegeneration in Dentate Gyrus and CA1 Regions of Hippocampus via CREB/BDNF Pathway in Rats

  2017cites this paper
• Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.

  2017cites this paper
• A Randomized Trial Evaluating Whether Topiramate Aids Smoking Cessation and Prevents Alcohol Relapse in Recovering Alcohol‐Dependent Men

  2017cites this paper
• Topiramate and motivational enhancement therapy for cannabis use among youth: a randomized placebo‐controlled pilot study

  2017cites this paper
• Mediatory role of NMDA, AMPA/kainate, GABAA and Alpha2 receptors in topiramate neuroprotective effects against methylphenidate induced neurotoxicity in rat

  2017cites this paper
• The efficacy of topiramate in alcohol dependence therapy – current research and prospects of use

  2017cites this paper
• Possible involvement of CREB/BDNF signaling pathway in neuroprotective effects of topiramate against methylphenidate induced apoptosis, oxidative stress and inflammation in isolated hippocampus of rats: Molecular, biochemical and histological evidences.

  2017cites this paper
• Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions

  2016cites this paper
• An update on the pharmacotherapeutic interventions for smoking cessation

  2016cites this paper
• Quantitative Determination of Topiramate in Human Breast Milk

  2016cites this paper
• Balancing risk and benefit in heavy drinkers treated with topiramate: implications for personalized care.

  2016cites this paper
• Nicotine‐induced locomotor sensitization: pharmacological analyses with candidate smoking cessation aids

  2016cites this paper
• Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.

  2016cites this paper
• HPTLC Method for Estimation of Topiramate in Solubility Studies, Diffusion Studies, Plasma, Brain Homogenate and Pharmaceutical Formulation.

  2016cites this paper
• A Call to Arms: The Role of the Psychiatry Resident in the Current Opioid Epidemic

  2016influential citation
• New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?

  2016cites this paper
• Tobacco Cessation Treatment Pathways for Patients With Cancer: 10 Years in the Making.

  2016cites this paper
• Glutamatergic transmission in drug reward: implications for drug addiction

  2015cites this paper
• Topiramate: a review of analytical approaches for biological matrices.

  2015cites this paper
• Gene-gene interaction of μ-opioid receptor and GluR5 kainate receptor subunit is associated with smoking behavior in a Greek population: presence of a dose allele effect

  2015cites this paper
• Clinical neuroscience of addiction: similarities and differences between alcohol and other drugs.

  2015cites this paper
• Topiramate: A Review of Analytical Approaches for the Drug Substance, Its Impurities and Pharmaceutical Formulations.

  2015cites this paper
• Women and Smoking: The Effect of Gender on the Epidemiology, Health Effects, and Cessation of Smoking

  2014cites this paper
• Tobacco use and cessation for cancer survivors: An overview for clinicians

  2014cites this paper